started · updated
Health Insurance Fund of Republika Srpska clarifies progesterone medication costs
The Health Insurance Fund (FZO) of Republika Srpska has issued a clarification following complaints from pregnant women regarding out-of-pocket costs for the medication Utrogestan. The Fund denied allegations that free therapy has been abolished, stating that the right to free progesterone remains unchanged.
According to the FZO, the fund covers the generic drug progesterone for all pregnant women with medical indications, as well as women undergoing in vitro fertilization. The current issue arises from a reference pricing system used since 2008 to encourage lower prices from suppliers.
While a new supplier has provided a lower-priced option that meets the reference price, women who choose a specific brand whose price exceeds this reference point must pay the difference, which is approximately 1.20 KM per box. The Fund emphasized that all contracted pharmacies are required to provide the medication at the reference price, and that the pricing lists are publicly available.
Entities
Health Insurance Fund of Republika Srpska · Republika Srpska